Similar articles for PMID: 24614107

Year	Number of Results
1994	1
2006	1
2008	1
2009	1
2010	1
2011	5
2012	7
2013	9
2014	13
2015	13
2016	16
2017	10
2018	13
2019	9
2020	4
2021	1
2022	1

1

An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.

Bonsignori M, Wiehe K, Grimm SK, Lynch R, Yang G, Kozink DM, Perrin F, Cooper AJ, Hwang KK, Chen X, Liu M, McKee K, Parks RJ, Eudailey J, Wang M, Clowse M, Criscione-Schreiber LG, Moody MA, Ackerman ME, Boyd SD, Gao F, Kelsoe G, Verkoczy L, Tomaras GD, Liao HX, Kepler TB, Montefiori DC, Mascola JR, Haynes BF. Bonsignori M, et al. J Clin Invest. 2014 Apr;124(4):1835-43. doi: 10.1172/JCI73441. Epub 2014 Mar 10. J Clin Invest. 2014. PMID: 24614107 Free PMC article.

2

9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity.

Kobie JJ, Alcena DC, Zheng B, Bryk P, Mattiacio JL, Brewer M, Labranche C, Young FM, Dewhurst S, Montefiori DC, Rosenberg AF, Feng C, Jin X, Keefer MC, Sanz I. Kobie JJ, et al. PLoS One. 2012;7(4):e35356. doi: 10.1371/journal.pone.0035356. Epub 2012 Apr 18. PLoS One. 2012. PMID: 22530008 Free PMC article.

3

High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site.

Sundling C, Li Y, Huynh N, Poulsen C, Wilson R, O'Dell S, Feng Y, Mascola JR, Wyatt RT, Karlsson Hedestam GB. Sundling C, et al. Sci Transl Med. 2012 Jul 11;4(142):142ra96. doi: 10.1126/scitranslmed.3003752. Sci Transl Med. 2012. PMID: 22786681 Free PMC article.

4

Will studies in individuals with systemic lupus erythematosus be the key to future HIV vaccine design?

Bonsignori M. Bonsignori M. Expert Rev Vaccines. 2014 Nov;13(11):1271-3. doi: 10.1586/14760584.2014.938056. Epub 2014 Jul 12. Expert Rev Vaccines. 2014. PMID: 25017952 Free PMC article.

5

HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes.

Ditse Z, Muenchhoff M, Adland E, Jooste P, Goulder P, Moore PL, Morris L. Ditse Z, et al. J Virol. 2018 Aug 16;92(17):e00878-18. doi: 10.1128/JVI.00878-18. Print 2018 Sep 1. J Virol. 2018. PMID: 29950423 Free PMC article.

6

Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.

Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, Wang C, Chen X, Longo NS, Louder M, McKee K, O'Dell S, Perfetto S, Schmidt SD, Shi W, Wu L, Yang Y, Yang ZY, Yang Z, Zhang Z, Bonsignori M, Crump JA, Kapiga SH, Sam NE, Haynes BF, Simek M, Burton DR, Koff WC, Doria-Rose NA, Connors M; NISC Comparative Sequencing Program, Mullikin JC, Nabel GJ, Roederer M, Shapiro L, Kwong PD, Mascola JR. Wu X, et al. Science. 2011 Sep 16;333(6049):1593-602. doi: 10.1126/science.1207532. Epub 2011 Aug 11. Science. 2011. PMID: 21835983 Free PMC article.

7

HIV-1 gp120-CD4-Induced Antibody Complex Elicits CD4 Binding Site-Specific Antibody Response in Mice.

Galkin A, Chen Y, Guenaga J, O'Dell S, Acevedo R, Steinhardt JJ, Wang Y, Wilson R, Chiang CI, Doria-Rose N, Grishaev AV, Mascola JR, Li Y. Galkin A, et al. J Immunol. 2020 Mar 15;204(6):1543-1561. doi: 10.4049/jimmunol.1901051. Epub 2020 Feb 17. J Immunol. 2020. PMID: 32066595 Free PMC article.

8

Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.

Jia M, Lu H, Markowitz M, Cheng-Mayer C, Wu X. Jia M, et al. J Virol. 2016 Mar 28;90(8):4017-4031. doi: 10.1128/JVI.02898-15. Print 2016 Apr. J Virol. 2016. PMID: 26842476 Free PMC article.

9

Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization.

Willis JR, Finn JA, Briney B, Sapparapu G, Singh V, King H, LaBranche CC, Montefiori DC, Meiler J, Crowe JE Jr. Willis JR, et al. Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4446-51. doi: 10.1073/pnas.1518405113. Epub 2016 Apr 4. Proc Natl Acad Sci U S A. 2016. PMID: 27044078 Free PMC article.

10

Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.

McGuire AT, Glenn JA, Lippy A, Stamatatos L. McGuire AT, et al. J Virol. 2014 Mar;88(5):2645-57. doi: 10.1128/JVI.03228-13. Epub 2013 Dec 18. J Virol. 2014. PMID: 24352455 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed